SCHEMBL11301756

SCHEMBL11301756

COc1cccc(N(c2ccc(C(N)=O)c(O)c2)C2CNC(=O)C2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.39
▸ MTNR1A P48039 3/20 0.37
▸ MTNR1B P49286 2/20 0.36
▸ OPRM1 P35372 2/20 0.36
▸ OPRD1 P41143 2/20 0.36
▸ OPRK1 P41145 1/20 0.35
▸ CDC7 O00311 1/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ ABCG2 Q9UNQ0 1/20 0.34
▸ HPGDS O60760 2/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ PGR P06401 1/20 0.34
▸ ADORA3 P0DMS8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11301767 0.68 RPS6KB1 (0.42) MTNR1AMTNR1BALDH1A1LMNA
SCHEMBL1447373 0.67 NPC1 (0.72) PARP1RAB9ASMN1; SMN2NPC1ABCG2
Potassium SCHEMBL31026152 0.65 NPC1 (0.70) PARP1RAB9ASMN1; SMN2NPC1ABCG2
SCHEMBL8042418 0.61 PDE4A (0.62) MTNR1ACYP3A4ALDH1A1MAPK1LMNA
SCHEMBL1268402 0.61 PDE4A (0.62) MTNR1ACYP3A4ALDH1A1MAPK1LMNA
SCHEMBL8041637 0.61 PDE4A (0.62) MTNR1ACYP3A4ALDH1A1MAPK1LMNA
SCHEMBL28382188 0.61 PARP1 (0.56) PARP1MTNR1AMTNR1B
SCHEMBL12316301 0.61 MAOA (0.55) PARP1RAB9ASMN1; SMN2NPC1HPGD
SCHEMBL27587725 0.61 ESR1 (0.50) PARP1MTNR1AMTNR1BAR
SCHEMBL3820208 0.60 PARP1 (0.48) PARP1MTNR1AMTNR1BCDC7RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback